Table 2.
Effect of cannabinoids on cytokine and chemokine production.
| Cannabinod | Receptor | Cell/tissue/serum | Effect | Ref. |
|---|---|---|---|---|
| THC | ND | Macrophage cell line (RAW264.7) | Decreases TNF-α | [40] |
| THC | ND | Peritoneal macrophages | Increases IL-1α and IL-1β | [41] |
| THC | ND | Human cell lines | Decreases TNF-α, GM-CSF and IFN-γ, IL-10 Increases IL-8 |
[26] |
| THC | CB1 and CB2 independent | Rat microglial cells | Decreases TNF-α, IL-1α, IL-1β and IL-6 | [28] |
| In vivo WIN55,212-2 and HU-210 | CB1 dependent | Serum | Decreases TNF-α, IL-12 Increases IL-10 |
[29] |
| Ajulemic acid | ND | Human synovial monocyte-derived macrophage | Decreases IL-6 and IL-1β | [32] |
| HU-308 | CB2 dependent | Serum and liver homogenates | Decreases TNF-α, MIP-1α and MIP-2 | [33] |
| CP55,940 WIN55,212–2 | CB1 and CB2 independent | Rheumatoid fibroblast-like synoviocytes | IL-6 and IL-8 | [34] |
| 2-AG | CB2 dependent | Promyelocytic leukemia cell line (HL-60) | Increases IL-8, CXCL8 and CCL2 | [37] |
AG: Arachidonoylglycerol; CB: Cannabinoid receptor; CCL: CC-chemokine ligand; CXCL8: CXC-chemokine ligand 8; ND: Not determined; THC: Tetrahydrocannabinol.